Frankfurt - Delayed Quote EUR
Armata Pharmaceuticals, Inc. (TG1N.F)
1.0500
-0.0100
(-0.94%)
At close: April 25 at 3:49:30 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
42,436
42,436
40,890
36,946
23,822
Operating Income
-42,436
-42,436
-40,890
-36,946
-23,822
Net Non Operating Interest Income Expense
-10,045
-10,045
-2,447
29
-59
Other Income Expense
33,565
33,565
-25,708
--
726
Pretax Income
-18,916
-18,916
-69,045
-36,917
-23,155
Net Income Common Stockholders
-18,916
-18,916
-69,045
-36,917
-23,155
Diluted NI Available to Com Stockholders
-18,916
-18,916
-69,045
-36,917
-23,155
Basic EPS
-1.15
-0.52
-1.91
-1.08
-0.96
Diluted EPS
-1.15
-0.89
-1.91
-1.08
-0.96
Basic Average Shares
36,140.3270
36,160.8480
36,075.5550
34,294.1240
24,104.1460
Diluted Average Shares
36,140.3270
59,059.9710
36,075.5550
34,294.1240
24,104.1460
Total Operating Income as Reported
-42,436
-42,436
-40,890
-36,946
-23,822
Total Expenses
42,436
42,436
40,890
36,946
23,822
Net Income from Continuing & Discontinued Operation
-18,916
-18,916
-69,045
-36,917
-23,155
Normalized Income
-21,082
-21,082
-65,182
-36,917
-23,881
Interest Income
697
697
179
29
5
Interest Expense
10,742
10,742
2,626
--
64
Net Interest Income
-10,045
-10,045
-2,447
29
-59
EBIT
-8,174
-8,174
-66,419
-36,917
-23,091
EBITDA
-6,849
-6,849
-65,447
-36,025
-21,922
Reconciled Depreciation
1,325
1,325
972
892
1,169
Net Income from Continuing Operation Net Minority Interest
-18,916
-18,916
-69,045
-36,917
-23,155
Total Unusual Items Excluding Goodwill
2,166
2,166
-3,863
--
726
Total Unusual Items
2,166
2,166
-3,863
--
726
Normalized EBITDA
-9,015
-9,015
-61,584
-36,025
-22,648
12/31/2021 - 5/15/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade